Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016. [electronic resource]
Producer: 20200622Description: 101-105 p. digitalISSN:- 1651-226X
No physical items for this record
Publication Type: Letter; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.